ATHIX Bio: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ATHIX Bio
Largest movements
- Cash -€3,420
down €3,420 (-44.8%), from €7,631 to €4,211
mainly Trade debts (-€5,998) and Tax, wage and social debts (-€2,024)
- Stocks and contracts -€2,905
down €2,905 (-27.0%), from €10,751 to €7,846
- Receivables within one year -€2,377
down €2,377 (-11.6%), from €20,556 to €18,179
of which Trade receivables: -€6,145
- Deferred charges and accrued income +€691
new in 2025: €691
- Trade debts -€5,998
down €5,998 (-36.0%), from €16,642 to €10,645
- Tax, wage and social debts -€2,024
down €2,024 (-74.8%), from €2,703 to €680
of which Remuneration and social security: -€1,100
- Profit (loss) carried forward +€467
up €467 (+45.1%), from €1,036 to €1,503
- Other debts -€457
no longer reported in 2025 (was €457)
- Gross operating margin -€5,093
down €5,093 (-81.3%), from €6,265 to €1,172
- Other operating charges -€579
down €579 (-51.4%), from €1,127 to €548
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €39,438 | €31,427 | -€8,011 | -20.3% |
| Fixed assets | 21/28 | €500 | €500 | = | 0.0% |
| Financial fixed assets | 28 | €500 | €500 | = | 0.0% |
| Current assets | 29/58 | €38,938 | €30,927 | -€8,011 | -20.6% |
| Stocks and contracts in progress | 3 | €10,751 | €7,846 | -€2,905 | -27.0% |
| Stocks | 30/36 | €10,751 | €7,846 | -€2,905 | -27.0% |
| Amounts receivable within one year | 40/41 | €20,556 | €18,179 | -€2,377 | -11.6% |
| Trade receivables | 40 | €19,556 | €13,412 | -€6,145 | -31.4% |
| Other amounts receivable | 41 | €1,000 | €4,768 | +€3,768 | +377% |
| Cash at bank and in hand | 54/58 | €7,631 | €4,211 | -€3,420 | -44.8% |
| Deferred charges and accrued income | 490/1 | - | €691 | +€691 | |
| Total equity and liabilities | 10/49 | €39,438 | €31,427 | -€8,011 | -20.3% |
| Equity | 10/15 | €19,636 | €20,103 | +€467 | +2.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,036 | €1,503 | +€467 | +45.1% |
| Amounts payable | 17/49 | €19,802 | €11,325 | -€8,478 | -42.8% |
| Amounts payable within one year | 42/48 | €19,802 | €11,325 | -€8,478 | -42.8% |
| Trade debts | 44 | €16,642 | €10,645 | -€5,998 | -36.0% |
| Suppliers | 440/4 | €16,642 | €10,645 | -€5,998 | -36.0% |
| Taxes, remuneration and social security | 45 | €2,703 | €680 | -€2,024 | -74.8% |
| Taxes | 450/3 | €1,603 | €680 | -€924 | -57.6% |
| Remuneration and social security | 454/9 | €1,100 | - | -€1,100 | |
| Other amounts payable | 47/48 | €457 | - | -€457 | |
| Other operating charges | 640/8 | €1,127 | €548 | -€579 | -51.4% |
| Gross operating margin | 9900 | €6,265 | €1,172 | -€5,093 | -81.3% |
| Operating profit (loss) | 9901 | €5,137 | €623 | -€4,514 | -87.9% |
| Financial income | 75/76B | €3 | €12 | +€9 | +315% |
| Recurring financial income | 75 | €3 | €12 | +€9 | +315% |
| Financial charges | 65/66B | €228 | €168 | -€60 | -26.2% |
| Recurring financial charges | 65 | €228 | €168 | -€60 | -26.2% |
| Profit (loss) for the period before taxes | 9903 | €4,912 | €467 | -€4,446 | -90.5% |
| Profit (loss) for the period | 9904 | €4,912 | €467 | -€4,446 | -90.5% |
| Profit (loss) for the period to be appropriated | 9905 | €4,912 | €467 | -€4,446 | -90.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.